Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
about
Mitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndromeDipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceA method for assessing mitochondrial bioenergetics in whole white adipose tissues.Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemOvernutrition, mTOR signaling, and cardiovascular diseases.Estrogen and mitochondria function in cardiorenal metabolic syndrome.Autophagy: a housekeeper in cardiorenal metabolic health and diseaseAsthma and metabolic syndrome: Current knowledge and future perspectives.Antioxidant capacity and concentration of redox-active trace mineral in fully weaned intra-uterine growth retardation piglets.Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.Sensory nerve terminal mitochondrial dysfunction activates airway sensory nerves via transient receptor potential (TRP) channelsMitochondrial dysfunction in metabolic syndrome and asthma.Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese ratsDPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.Amelioration of cardio-renal injury with aging in dahl salt-sensitive rats by H2-enriched electrolyzed water.Insulin resistance and heart failure: molecular mechanismsMitochondrial alteration in type 2 diabetes and obesity: an epigenetic link.Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).Forsythiae Fructus Inhibits B16 Melanoma Growth Involving MAPKs/Nrf2/HO-1 Mediated Anti-Oxidation and Anti-Inflammation.The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome.The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.Emerging roles of SIRT1 in fatty liver diseases.From the Cover: Alcohol Inhibition of the Enzymatic Activity of Glyceraldehyde 3-Phosphate Dehydrogenase Impairs Cardiac Glucose Utilization, Contributing to Alcoholic Cardiomyopathy.Cellular Mechanisms Underlying Obesity-Induced Arterial Stiffness.Astragalus polysaccharides protect cardiac stem and progenitor cells by the inhibition of oxidative stress-mediated apoptosis in diabetic hearts.Role of autophagy in a model of obesity: A long‑term high fat diet induces cardiac dysfunctionSelective mitochondrial staining with small fluorescent probes: importance, design, synthesis, challenges and trends for new markersAstragalus polysaccharides inhibit oxidation in high glucose-challenged or SOD2-silenced H9C2 cells
P2860
Q28650861-0EDB00F1-610C-4BE5-BB6F-0F6BB3219EE7Q33644666-3BF8773E-E029-4B9A-9FB8-C324F6FB3A5CQ33737350-18275EC3-4DD9-4E1B-89EA-A026ACE42A60Q33894127-101EAAFE-18D0-4C88-9E51-C3E59560F01EQ34062829-6AEF0267-2808-48E8-AF04-77BF7DA6B3E0Q34519316-4F9E4ADE-A10B-42CF-BFD6-5067C888AE9DQ35054122-6EEF164C-CC9E-4EAA-91D7-0F2C21A994DDQ35112261-1145FD19-9DC9-4BFA-80B0-457F98A3F848Q35179339-ECEFECE7-355F-4A4E-8277-DC48412EC5E3Q36298482-E7F37233-E4F8-48EF-993A-C8CD8F83BA25Q36674142-2383CF85-3FF3-4778-BECE-EEED0FF07D6DQ36776716-7F90DBB8-54A1-41DD-9C0A-7BD9DE8196F6Q36942788-74D04C6A-2FEB-4296-B796-EF47E7CB83E4Q36946065-D1515245-CF7A-469B-A117-ED06174AB6EBQ37095161-11F1360A-B221-40D0-955F-88C5A8441608Q37400210-3890C506-90AC-46D6-BCE0-F5738587911EQ38045550-CC5D8616-F201-40DF-B718-2B1602EB2C09Q38189524-30DDD863-E854-4FC5-AF7A-05C45A9A95BDQ38267493-B81CF9B4-27E9-4B8D-9B06-115D480E895DQ38757324-EB350257-DFD1-4860-8F96-E5C0D27D8B87Q39370913-B21A0D53-4F7B-4463-B757-E29535874C40Q40552347-7AAFED25-9B4B-4961-B39E-08DC1F312336Q41377073-27264485-2350-4219-AFD6-E83C503FE7C7Q47724513-0F8F6477-B4A9-4C9F-8AC7-EEB77DEEAA4AQ49789137-9694752F-310F-45BF-BC7F-2CEA046C2CDBQ55382866-AC1167CB-8BE0-4E16-8B10-C96B95F196E8Q56396155-07896B56-9FB7-4274-B5D5-4ABF6E595142Q58337810-10C6F181-16BE-4791-8586-91ABFEF2A713Q58698710-9D126CBF-F254-4445-8597-8DB825A01492
P2860
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@ast
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@en
type
label
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@ast
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@en
prefLabel
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@ast
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@en
P2093
P2860
P356
P1433
P1476
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
@en
P2093
Annayya R Aroor
Chirag Mandavia
James R Sowers
Lakshmi Pulakat
P2860
P304
P356
10.1159/000335675
P577
2012-02-07T00:00:00Z